Fostemsavir tromethamine - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for fostemsavir tromethamine and what is the scope of patent protection?
Fostemsavir tromethamine
is the generic ingredient in one branded drug marketed by Viiv Hlthcare and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Fostemsavir tromethamine has thirty-nine patent family members in thirty countries.
One supplier is listed for this compound.
Summary for fostemsavir tromethamine
| International Patents: | 39 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Patent Applications: | 127 |
| What excipients (inactive ingredients) are in fostemsavir tromethamine? | fostemsavir tromethamine excipients list |
| DailyMed Link: | fostemsavir tromethamine at DailyMed |
US Patents and Regulatory Information for fostemsavir tromethamine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | RUKOBIA | fostemsavir tromethamine | TABLET, EXTENDED RELEASE;ORAL | 212950-001 | Jul 2, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Viiv Hlthcare | RUKOBIA | fostemsavir tromethamine | TABLET, EXTENDED RELEASE;ORAL | 212950-001 | Jul 2, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Viiv Hlthcare | RUKOBIA | fostemsavir tromethamine | TABLET, EXTENDED RELEASE;ORAL | 212950-001 | Jul 2, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Viiv Hlthcare | RUKOBIA | fostemsavir tromethamine | TABLET, EXTENDED RELEASE;ORAL | 212950-001 | Jul 2, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for fostemsavir tromethamine
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Israel | 177945 | PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS | See Plans and Pricing |
| South Africa | 200607466 | Prodrugs of piperazine and substituted piperidine antiviral agents | See Plans and Pricing |
| Malaysia | 139243 | PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS. | See Plans and Pricing |
| Russian Federation | 2006136390 | ПИПЕРАЗИНОВЫЕ ПРОЛЕКАРСТВА И ЗАМЕЩЕННЫЕ ПИПЕРИДИНОВЫЕ ПРОТИВОВИРУСНЫЕ АГЕНТЫ | See Plans and Pricing |
| Hong Kong | 1148533 | PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
